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airflow obstruction
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Konrad Muller1, Chris Ward2 & Sukhwinder Singh Sohal1,3
COPD is characterised by poorly reversible airflow obstruction usually due to cigarette smoking. The 
transcription factor clusters of β-catenin/Snail1/Twist has been implicated in the process of epithelial 
mesenchymal transition (EMT), an intermediate between smoking and airway fibrosis, and indeed lung 
cancer. We have investigated expression of these transcription factors and their “cellular localization” 
in bronchoscopic airway biopsies from patients with COPD, and in smoking and non-smoking controls. 
An immune-histochemical study compared cellular protein expression of β-catenin, Snail1 and Twist, 
in these subject groups in 3 large airways compartment: epithelium (basal region), reticular basement 
membrane (Rbm) and underlying lamina propria (LP). β-catenin and Snail1 expression was generally 
high in all subjects throughout the airway wall with marked cytoplasmic to nuclear shift in COPD 
(P < 0.01). Twist expression was generalised in the epithelium in normal but become more basal and 
nuclear with smoking (P < 0.05). In addition, β-catenin and Snail1 expression, and to lesser extent of 
Twist, was related to airflow obstruction and to expression of a canonical EMT biomarker (S100A4). The 
β-catenin-Snail1-Twist transcription factor cluster is up-regulated and nuclear translocated in smokers 
and COPD, and their expression is closely related to both EMT activity and airway obstruction.
Chronic obstructive pulmonary disease (COPD) is mainly smoking-related and primarily reflects small airway 
fibrosis and destruction with later development of emphysema in some. Approximately 50% of smokers develop 
COPD eventually1, 2 and probably significantly more if specific small airway measurements are used3 for assess-
ment. COPD is also strongly related to lung cancer development4–6.
We and others have described active EMT in the airway epithelium smokers and especially in COPD7–9. This 
is likely to be related to epithelial basal stem cell reprogramming10. There is some work, mainly in epithelial cell 
culture on the mechanisms of EMT in the airways11. But we also recently reported evidence in airway biopsies for 
involvement of TGF-β1 and its Smad transcription factor system12.
β-catenin is physiologically part of a major cell-surface adhesion complex13 but if released from there becomes 
part of another important pro-pathological transcriptional factor cascade. This is classically induced by Wnt 
(Wingless tail) ligand activating the Frizzled cell surface receptor14–16. We hypthesise that β-catenin may be 
involved in airway EMT activity, following a recent report of increased Wnt expression in lung epithelial cells 
from COPD patients17.
Binding of Wnt ligand to the Frizzled receptor induces its phosphorylation and through this inactivation 
of the cytoplasmic β-catenin sequester, glycogen synthase kinase-3β(GSK-3β)18. This contributes to cytosolic 
accumulation of β-catenin and then nuclear translocation where it binds with lymphoid enhancing binding fac-
tor (LEF-1). In addition, TGF-β1 can signal to increase LEF-1 expression through SMADs and also to inhibit 
GSK-3β19, 20.
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Snail1, is a zinc finger binding transcription factor, repressing transcription of membrane adhesions, so releas-
ing β-catenin21, 22. Reciprocally, the Wnt-β-catenin and PI3K-AKT mechanism also increase Snail1 activity by 
preventing its phosphorylation by GSK-3β, which enhances EMT23. A mutual interaction also seems to exist 
between SMADs and Snail1 for induction of EMT24, 25.
Twist is a basic helix-loop-helix transcription factor which also plays a key role in EMT progression26. As with 
Snail1, Twist expression down-regulates epithelial gene expression and activates mesenchymal gene expression27. 
Twist activity intracellularly is augmented by its phosphorylation by mitogen activated protein kinase (MAPK)28.
Figure 1. Representative photomicrograph of β-catenin expression in 4 different study groups: (A) healthy 
non-smokers (N-C), (B) smokers with normal lung function (NLFS), (C) current smoking COPD (COPD-CS) 
and (D) ex-smokers with COPD (COPD-EX). Original magnification, ×400. Scale bar = 50 µm.
Figure 2. Photomicrographs of Snail1 expression representing 4 different study groups: (A) healthy non-
smokers (N-C), (B) smokers with normal lung function (NLFS), (C) current smoking COPD (COPD-CS) and 
(D) ex-smokers with COPD (COPD-EX). Original magnification, ×400. Scale bar = 50 µm.
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The role of this key EMT-related transcriptional factor cluster (β-catenin, Snail1 and Twist) specifically 
in development and progression of airway remodelling in smokers/COPD is still largely unexplored, but our 
hypothesis is that this system is intimately involved in EMT activity in the airways and its down-stream patho-
physiological consequences, as well as having cross-relationship with the SMAD pathway system. Thus, the 
Figure 3. Representative photomicrograph of Twist expression in 4 different study groups: (A) healthy non-
smokers (N-C), (B) smokers with normal lung function (NLFS), (C) current smoking COPD (COPD-CS) and 
(D) ex-smokers with COPD (COPD-EX). Original magnification, ×400. Scale bar = 50 µm.
Figure 4. Cytoplasmic versus nuclear % basal cells expressing: (A) β-catenin (B) Snail1 and (C) Twist; 
comparing healthy non-smokers (N-C) n = 15, smokers with normal lung function (NLFS) n = 15, current 
smoking COPD (COPD-CS) n = 20 and ex-smokers with COPD (COPD-EX) n = 15.
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present study has evaluated their protein expression and cellular compartmentalisation in airway biopsies from 
COPD subjects and appropriate controls. We have also explored relationships between these transcriptional fac-
tors and EMT activity (represented by the mesenchymal marker S100A4), with TGFβ1 and SMADs, and finally 
with airflow obstruction as the final functional outcome of these complex processes.
Results
Large airway. Basal cells. β-catenin: There was general staining for β-catenin in the basal cells of airway 
epithelium in all groups with no difference in % of cells expressing it. However, there were striking change in the 
cellular distribution of β-catenin from cell membrane to cytoplasm in normal lung function smokers (NLFS) and 
COPD-Ex, but also to the nucleus in COPD current smokers (COPD-CS). The ratio of number of cells with pre-
dominant nuclear rather than cytoplasmic predominance was significantly higher in COPD-CS in comparison to 
both normal control (NC) and NLFS (P < 0.01) with COPD-Ex being intermediate (Figs 1 and 4).
Snail1: Snail1 expression was less uniform among basal cells, but there was a significant increase in percent 
cells expression in both NLFS and COPD-CS (P < 0.05). In addition, there was again a significant shift from cyto-
plasmic to nuclear expression only in the COPD-CS group (P < 0.01) though with an intermediate change from 
NC, in the NLFS and COPD-Ex groups (P < 0.01) (Figs 2 and 4).
Twist: Twist expression was prominent in the NC group but only in the more apical cell areas. In contrast, there 
was more basal cell expression in all other groups (P < 0.01). There was shift from the cytoplasmic to nuclear com-
partment expression only in the 2 groups, NLFS and COPD-Ex (P < 0.05), and not in COPD- CS (Figs 3 and 4).
Rbm cells. β-catenin: There was little difference in general cellular staining between the 4 study groups, but a 
small though significant shift from cytoplasmic to nuclear expression in both NLFS and COPD-CS(P < 0.05) 
(Figs 1 and 5), with corresponding increase in nuclear to cytoplasmic ratios (P < 0.05), i.e. a smoking effect only.
Snail1: There was similar and substantial staining of Snail1 in Rbm cells in all 4 groups, but with a marked 
shift from cytoplasmic to nuclear expression in the 3 clinical groups compared to NC (P < 0.05) (Figs 2 and 5), 
reflected again in increased nuclear to cytoplasmic ratio for these groups (P < 0.05), i.e. again more of a smoking 
than COPD effect.
Twist: There was increased expression of Twist in NLFS as compared NC subjects with a small but significant 
shift towards nuclear expression in both NLFS and COPD-Ex groups (P < 0.05) (Figs 3 and 5) (also P < 0.05 for 
the corresponding change in nuclear to cytoplasmic ratio). There was little change in the COPD-CS group.
LP cells. β-catenin: Matrix staining for β-catenin was observed in NC only, and was absent in all clinical groups, 
suggesting some change in physico-chemical interactions with matrix proteins. Among LP cells, only approxi-
mately 20% of them expressing β-catenin (and the other transcription factors) in each group, but there was a shift 
in these cells in β-catenin staining to nuclear expression in both NLFS and COPD-CS compared to NC (P < 0.05) 
Figure 5. Cytoplasmic versus nuclear % Rbm cells expressing: (A) β-catenin (B) Snail1 and (C) Twist; 
comparing healthy non-smokers (N-C) n = 15, smokers with normal lung function (NLFS) n = 15, current 
smoking COPD (COPD-CS) n = 20 and ex-smokers with COPD (COPD-EX) n = 15.
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Figure 6. Cytoplasmic versus nuclear % LP cells stained with: (A) β-catenin (B) Snail1 and (C) Twist; 
comparing healthy non-smokers (N-C) n = 15, smokers with normal lung function (NLFS) n = 15, current 
smoking COPD (COPD-CS) n = 20 and ex-smokers with COPD (COPD-EX) n = 15.
Figure 7. Regression analyses for the current-smoking COPD group (COPD-CS) n = 12: (A) Correlation 
between number of basal epithelial cells per mm of Rbm, positive for β-catenin and forced expiratory ratio 
(FER); (B) The same for % predicted FEF25-75 (an index of small airway calibre); (C) Correlation between 
Snail1 positive basal epithelial cells and forced expiratory ratio (FER); (D) Correlation between basal epithelial 
cells positive for Snail1 with % predicted FEF25-75.
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Figure 9. Regression analyses for the current-smoking COPD group (COPD-CS) n = 12: (A) Correlation between 
number of β-catenin positive basal epithelial cells per mm of Rbm, with TGFβ1 positive basal epithelial cells; (B) 
Correlation between number of basal epithelial cells positive for β-catenin with pSmad 2/3 positive basal epithelial 
cells; (C) Correlation between basal epithelial cells expressing Snail1 with pSmad 2/3 positive basal epithelial cells.
Figure 8. Regression analyses for the current-smoking COPD group (COPD-CS) n = 12: (A) Correlation between 
number of basal epithelial cells per mm of Rbm, positive for β-catenin with S100A4 positive basal epithelial cells; 
(B) Correlation between number of Rbm cells per mm of Rbm, expressing β-catenin with S100A4 positive Rbm 
cells; (C) Correlation between number of basal epithelial cells per mm of Rbm, positive for Snail1 with S100A4 
positive basal cells; (D) Correlation between Rbm cells expressing Snail1 with S100A4 positive Rbm cells.
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(Figs 1 and 6). Similarly, nuclear to cytoplasmic ratio was also significantly higher in NLFS and COPD-CS 
(P < 0.05).
Snail1: No matrix staining was observed in any group. There was again a marked shift from cytoplasmic to 
nuclear cellular expression in the 3 clinical groups, but especially in NLFS and COPD-CS (P < 0.05) (Figs 2 and 
6), with a corresponding shift observed in nuclear to cytoplasmic ratio in NLFS and COPD-CS (P < 0.05).
Twist: Matrix was devoid of Twist staining in the LP in all groups. There was no difference in percent cell 
staining between groups with a shift from cytoplasmic to nuclear staining only in the COPD groups, especially 
in COPD-Ex smokers (P < 0.05) (Figs 3 and 6). In addition, nuclear to cytoplasmic ratio was also observed to be 
high in these COPD clinical groups (P < 0.05).
Regression Analyses. The relationships between β-catenin and Snail1 cell expressions, each independently 
with lung function, EMT activity (expressed by S100A4 expression) and TGFβ1-Smad pathway expression, were 
quite similar in all compartments (i.e. for basal cells, Rbm cells and LP cells). Relationship for Twist were weaker 
though still generally significant. In general, higher the expressions of the transcription factors, greater was EMT 
activity and also greater were the levels of airflow obstruction. These relationships were strongest for basal cells 
data and in COPD-CS (Figs 7–9). We have limited reporting the actual regressions to this specific clinical group 
because of their visually obvious as well as statistical strength and strategic importance.
Small airway. For comparative purpose, we have also stained for β-catenin expression in a small number of 
lung resection small airway samples from normal and COPD current smoking (COPD-CS). Although data are 
Figure 10. Representative photomicrograph of β-catenin expression in small airway of (A) healthy non-
smokers (N-C), (B) current smoker COPD (COPD-CS). β-catenin cellular staining is more abundant in 
COPD-CS subjects in the epithelium, but also in the Rbm and sub-epithelial lamina propria. The cellular 
localisation also changes from a membrane association only, to include the cytoplasmic and nuclear 
compartment, though difficult to visually differentiate at this magnification which is needed for “photo-
micrographs”.
Figure 11. Representative photomicrograph of E-cadherin expression in large airway of (A) healthy normal 
control non-smokers (N-C), and (B) current smoker COPD (COPD-CS). E-cadherin staining does not seems to 
hugely different between the two groups, although a slight decrease is likely, especially circumferentially, in basal 
epithelium cell expression in COPD-CS.
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descriptive only, there was consistently heavier cellular staining in all compartments (i.e. epithelial cells, Rbm 
and LP cells) in the COPD small airways compared to normal. There was also marked shift from cytoplasmic to 
nuclear expression in the COPD-CS group (Fig. 10).
Large airway epithelial E-Cadherin expression. Down-regulation of E-cadherin in conjunction to 
changes in β-catenin expression is an important step in EMT. Reduced expression of E-cadherin in COPD air-
ways has been reported before by Gohy et al.11, Oldenburger et al.29 and Milara et al.9. With nuclear localisation 
of β-catenin in large airway epithelium, we further explored E-cadherin expression in epithelium. We stained for 
E-cadherin in a small number of large airway samples from normal controls (N-C) and COPD current smoking 
(COPD-CS). Although data at this stage are preliminary and essentially descriptive only, there was quite strong 
suggestion of lower expression of E-cadherin in basal epithelial cells in COPD, especially at the margins of the 
cells (Fig. 11). However, overall, E-cadherin expression was quite high in the whole epithelium, which makes the 
signal-to-noise ratio overall quite weak.
Discussion
Smoking related COPD is a major disease of global significance. Its obstructive pathophysiology is predominantly 
due to small airways fibrosis and progressive luminal obliteration30. Some individuals go on to develop emphy-
sema31 and many also lung cancer, which should be regarded as part of the COPD32, 33. Although we do not yet 
fully understand the fundamental pathobiology of the core airway components of COPD, including widespread 
epithelial structural remodelling, it is most likely related to “reprogramming” of basal epithelial (stem) cells10. We 
have described active EMT throughout the airway tree in smokers and especially in COPD7, 8, 34, as a significant 
manifestation of this epithelial basal cell dysfunction35 and potentially a gateway to both airway fibrosis and lung 
cancer6, 33, 36, 37.
We have recently published on the TGF-β1-Smad pathway in COPD, and its relationships with both EMT and 
airway obstruction12. We have now addressed similar issues with the classic pro-EMT β-catenin-Snail1-Twist 
transcription factor cluster, usually thought to be activated by the Wnt system through cell surface Frizzled recep-
tors18, but as outlined in the introduction the regulation of the system is complex. However, we have now pro-
vided strong evidence for a general up-regulation of this system in smokers. In the basal epithelial cells, this 
up-regulation was even greater in COPD current smokers, though this was not so marked in Rbm and LP where 
changes were more of a smoking effect only. It suggests that smoking does activate EMT even without full-blown 
COPD, which might explain cancer development and some small airway disease even in “normal” smokers. 
However, in general these processes are more aggressive in COPD itself. Although the evidence is circumstantial 
at the moment, it seems likely that those “normal” individuals with the highest EMT signal in the airway will be 
those who go on to get full-blown COPD and to be most likely to develop lung cancer. Ideally, a study should be 
done to follow a statistically large enough number of normal lung function smokers over several years after initial 
bronchoscopy, endobronchial biopsy and tissue analysis, and then see who goes on to develop COPD with small 
airway fibrosis and/or lung cancer. Such a study will be highly informative but logistically very hard and very 
expensive to undertake.
A particular feature of these up-regulated transcription factor expressions from the cell cytoplasm (and in the 
case of β-catenin first from the cell membrane) into the cell nucleus. This was evident not only in the epithelial 
basal cells but also in the hyper-cellular Rbm and to an extent in lamina propria stromal cells. There were strong 
generalised associations between the expression of these transcription factors and EMT activity (using expression 
of the classic mesenchymal marker S100A4), and notably also airflow obstruction.
The E-Cadherin/β-catenin complex plays an important role in maintaining epithelial cell integrity, and 
disrupting this complex at cell margins affects not only the adhesive properties of the epithelium, but the 
Wnt-signaling pathway as well. In general, aberrant expression of this cell-surface complex is associated with a 
wide variety of epithelial malignancies and fibrotic pathologies resulting mainly from EMT. In large airways, we 
have undertaken some preliminary work showing likely decrease in epithelial E-cadherin expression but only 
in basal epithelial cells of COPD current smokers. However, this is not easy to quantitate, as E-cadherin is very 
abundant at a tissue level in the whole epithelium, which makes the basal cell signal quite weak in the context of 
the whole tissue, and much weaker than the β-catenin signal of down-regulation and nuclear transitioning. In a 
previous publication Gohy et al. showed a stronger signal for E-Cadherin reduction in COPD epithelium than 
in our current observations11; this difference may be methodological but we are as one in suggesting active EMT 
in this tissue.
Although several studies have demonstrated a role of the canonical Wnt/β-catenin signalling pathway in fibro-
sis and tissue remodelling38–40, little is known about how β-catenin may be involved in the pathology of COPD. 
Our observations do consolidate the recent report of Wnt up-regulation in COPD airways and its induction in 
cultured airway cells by cigarette smoke17. In addition, various growth factors, including TGF-β1, can activate 
β-catenin signalling either directly or via autocrine Wnt ligand production38, 41, 42 and this would fit with our 
observation of a significant cross-association with the TGF-β1 and SMAD2/3 pathways in these human tissue 
studies.
Stabilized (non-phosphorylated) β-catenin activates several targe genes including matrix metalloproteinases 
(MMP’s), growth factors, extracellular matrix (ECM) proteins and pro-inflammatory mediators and enzyme43–45 
and most importantly has been postulated as a key inducer of EMT in several tissues46, 47. In addition, Baarsma 
et al. observed that β-catenin expression is higher than normal in primary pulmonary fibroblast from COPD 
subjects48, which may reflect our findings in LP stromal cells.
Snail1 and Twist have been implicated previously in induction of EMT in COPD with protein and mRNA 
expression of mesenchymal markers and EMT-related transcription factors increased in cultured epithelial cells49. 
Our findings are novel in that we have not only shown a general increase in expression of transcriptional factors 
www.nature.com/scientificreports/
9SCiENTifiC REPORTS | 7: 10832  | DOI:10.1038/s41598-017-11375-x
in all airway wall compartments, but also a downstream cytoplasmic to nuclear shift in smokers and especially 
COPD. These changes were most evident in the basal epithelial cells in current smoker COPD. We suggest that 
this picture represents a fundamental key to understanding COPD pathogenesis. Most of our data presented here 
have come from endo-bronchial biopsies of large airways, but the limited data we have presented from small air-
way samples would suggest that the same key changes are present in COPD in the small airways where pathogenic 
airway fibrosis and obstruction is greatest.
β-catenin, Snail1 and Twist are intimately interlinked because the majority of β-catenin’s action is medi-
ated through the other two transcription factors50, 51. Twist as an important transcriptional factor for fibrosis 
was first demonstrated in a murine model of virus-induced lung fibrosis and in alveolar epithelial cells of idio-
pathic pulmonary fibrosis (IPF) patients52. Our data suggest that these processes are also active in the airways in 
smoking-related COPD.
Thus, one of the most remarkable findings in our current study was the significant correlation between basal 
epithelial cell transcription factor expression with both an EMT activity marker and also airflow obstruction. This 
latter “mechanistic” relationship gives our findings clinical and potentially translational relevance. However, we 
also found a strong relationship in our previous study between SMAD expression in the epithelium and airway 
obstruction12 though interestingly this was not found for TGF-β1 expression. This emphasises that factors other 
than this specific growth factor are also likely to be involved in driving EMT and down-stream airway fibrosis, 
making this a complex system unlikely to be amenable to a simple therapeutic intervention. Even so, the fact that 
there is a strong relationship between the β-catenin-Snail1-Twist transcription factor cluster and the previously 
studied Smad pathway suggests that TGF-activin drivers may be dominant.
The strengths of the present study include the use of relevant human tissue in well phenotyped individuals 
including mild to moderate COPD patients and comprehensive appropriate controls, and with fairly robust num-
bers giving sufficient power to detect these fascinating findings. We have focused on mild to moderate COPD 
patients, because active pathogenic mechanisms at this stage will be core ones, and not unduly influenced by later 
secondary complications such as infection leading to inflammation and immune activation in the airway lumen 
and without significant emphysema to affect airflow.
There are also some limitations to this study. Firstly, it is cross-sectional at a single time point and without the 
potential strength of longitudinal studies which could related variable transcriptional factors expression to indi-
vidual disease progression. It is noteworthy, for example, that even in the normal smoker control group (NLFS) 
there were quite strong relationships between transcription factors and decreasing lung function, even if tech-
nically all within the non-COPD range, suggesting that there are individuals on the way to full-blown COPD; 
one could also speculate that they may be of particular risk of lung cancer. Secondly, we are not sure about the 
detailed phenotype of the of LP cells expressing β-catenin/Snail1/Twist, although descriptively they seemed to be 
stromal cells and not immune/inflammatory. Double staining will be a future goal. Thirdly, our control subjects 
were somewhat younger than the smoker/COPD group, but transcription factor expression levels were not age 
related in any group; and finally, this study used many large airway biopsies while the predominant anatomic site 
of airflow limitation is in the small airways. We did this because recruiting volunteers for bronchoscopic airway 
sampling allowed us access to physically fit subjects with well-defined phenotypes including COPD subjects with 
relatively mild disease and without confounding drug treatment or the pathology present in resected lung tissues. 
Further, we know that although EMT is especially active in larger airways it is also present in small airways and 
lessons learned in one site is likely to reflect also what is happening throughout the airway tree; it is telling that 
both EMT activity7, 8, 34 and these current transcription factor expressions were strongly related to small airway 
function (FEF75-25%). Even so, it is now certainly well worth the effort to try and replicate these finding com-
prehensively in small airway samples. Our preliminary data from small airways presented here suggest that this 
will be well worthwhile.
Our general goal in this program over several years has been to comprehensively define the key underlying 
pathology in COPD airways, and latterly to define main drivers and transcriptional pathways that contribute to 
what we believe is a core part of the COPD end-phenotype, namely active airway EMT, and beyond that to airway 
fibrosis and obstruction in COPD. Here we have provided the evidence for involvement of β-catenin and related 
transcription factors. Other potential drivers of EMT include the Notch and Hedgehog (Hh) pathways, while 
others have implicated the uPAR53 and cAMP systems as well. The relative importance of these pathways needs 
further investigation.
Groups (numbers) NC (n = 15) NLFS (n = 15) COPD-CS (n = 20) COPD-EX (n = 15)
GOLD I/GOLD II ‡ N/A N/A 13/7 8/7
Male/female 7/8 11/4 12/8 9/6
Age (years) 44 (20–68) (p = 0.313) 50 (30–66) (p = 0.313) 61 (46–78) (p = 0.001)* 62 (53–69) (p = 0.001)*
Smoking (pack years) 0 32 (10–57) 45 (18–78) 51 (18–150)
FEV1% predicted (Post BD)† 113 (86–140) 99 (78–125) (p = 0.01)* 83 (66–102) (p < 0.001)* 83 (54–104) (p < 0.001)*
FEV1/FVC % (Post BD)† 82 (71–88) 77 (70–96) (p = 0.218) 59 (46–68) (p < 0.001)* 57 (38–68) p < 0.001)*
Table 1. Demographic detail and lung function data for participants. Data expressed as median and range. 
NC- Normal control; NLFS-Normal lung function smoker; COPD-CS-COPD current smoker; COPD-ES- 
COPD ex-smoker; N/A-Not any. *Significance difference from NC. †Post BD values after 400 µg of salbutamol. 
‡Diagnosis of COPD was made according to GOLD 2015 guidelines.
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Materials and Methods
Ethics approval. The Tasmania Health & Medical Human Research Ethics Committee approved the study 
(EC00337, Chief Investigator, Sohal SS). All subjects gave written, informed consent prior to participation and all 
methods were performed in accordance with the relevant guidelines and regulations.
Study Design. 65 subjects were recruited through advertisement. Bronchial biopsies (BB) from 15 smokers 
with NLFS, 20 COPD-CS and 15 ex-smokers with COPD (COPD-EX) were compared with 15 healthy nonsmok-
ers (NC) (Table 1). COPD was diagnosed according to Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) criteria54. Subjects with other respiratory diseases, a history of recent acute exacerbation of COPD were 
excluded from the study. COPD subjects were on PRN (as needed) bronchodilators for the most part, and espe-
cially none were using systemic or inhaled corticosteroids.
Tissue Processing and Immunostaining. Biopsies were first fixed in 10% neutral buffered formalin for 
2 hrs, then in 50% ethanol before processing on a Leica ASP 200 tissue processor. Paraffin embedded sections of 
3 mm were cut for staining, separated by at least 50 microns and mounted on slides. After removal of paraffin, 
sections were stained with either monoclonal antibody anti-β-catenin (abcam ab 22656 at 1/500 FOR 90 minutes 
at room temperature), monoclonal mouse anti-human E-cadherin (Dako, Clone NCH-38 at 1:30 for 40 minutes), 
rabbit polyclonal anti-Snail1 (abcam ab 180714 at 1/200 for 90 minutes at room temperature) after blocking with 
Dako serum block (X0909), following heat retrieval using a Dako PT link with high pH solution K800421 at 95 
degrees for 15 minutes and Rabbit polyclonal anti-Twist (Abcam ab50581 at 1:500 for 90 minutes at room tem-
perature) In each run a section stained with immunoglobulin (Ig) G1-negative control (X0931 clone DAKGO1; 
Dako Cytomation) was included to ensure absence of false positive staining and a known lung tissue positive 
tissue control was run with each staining. Bound antibodies were elaborated by using horseradish peroxidase 
(HRP) conjugated DAKO Envision plus reagent (cat no. K4001, anti-mouse or K4003 anti-rabbit) and diamin-
obenzidine (DAB) for a brown colour resolution (cat. no. K3468; Dako Cytomation). Nuclei were counterstained 
using Mayers Haematoxylin and sections dehydrated through ascending grades of ethanol, cleared in xylene and 
mounted in permount. We have extensively used and published with these methods12, 33, 34, 55–60.
Tissue section analysis and quantitation. All slides were coded and randomized to blind the per-
son who did the measurements (MM). We randomly choose five good fields for measurement from each slide, 
for each of the biomarkers. Only areas with intact epithelium and LP and without tissue damage were selected 
for measurement. Measurements were performed by computer-assisted image analysis using microscopy at 
40× magnification (Leica DM 2500, Microsystems, Germany), a Spot insight 12 digital camera (Spot imaging, 
USA) and Image Pro V5.1 software (Media Cybernetics, USA).
All biomarkers (β-catenin, Snail and Twist) were quantitated as number basal and apical epithelial cells stained 
along with their differential percentages according to localization of antibody (cytoplasmic versus nuclear). Cells 
stained in the Rbm per mm of Rbm were treated in the same way, a were LP cells as differential percentage. We 
quantified the membranous staining of individual cells (basal, Rbm and LP) by counting as positive cells those 
with approximately 90% of the cell membrane positive. For cytoplasmic and nuclear staining, quantification was 
done according to area of each compartment (cell cytoplasm and nucleus) stained, for all cell with >20% of cyto-
plasmic/nuclear area stained and where cytoplasmic and nuclear staining could be differentiated from each other.
Statistical analysis. Since the data were non-normally distributed, the results for each marker are presented 
as the median and range. Non-parametric ANOVA (Kruskal-Wallis) was first used to detect any overall differ-
ence among study groups, followed by Dunn’s multiple comparison test to specify which groups were different. 
Statistical analyses were performed using SPSS (statistics version 20.0, IBM Co, USA) for Windows 7.0 and a 
p-value of ≤0.05 was considered statistically significant.
Conclusion and Summary
In conclusion, we have shown that the β-catenin-Snail1-Twist transcription factor cluster is activated in smokers 
and especially in COPD in epithelial basal cells, and that their expression is remarkably closely related to both 
EMT activity and airway obstruction. We feel that this work is opening novel understanding of the fundamental 
mechanisms involved in COPD patho-physiology.
References
 1. Hogg, J. C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364, 709–721 (2004).
 2. Barnes, P. J. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 54, 113–129, doi:10.1146/annurev.
med.54.101601.152209 (2003).
 3. Johns, D. P., Walters, J. A. & Walters, E. H. Diagnosis and early detection of COPD using spirometry. J Thorac Dis 6, 1557–1569, 
doi:10.3978/j.issn.2072-1439.2014.08.18 (2014).
 4. Sohal, S. S. Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer: Epithelial Mesenchymal Transition (EMT), the 
Missing Link? EBioMedicine 2, 1578–1579, doi:10.1016/j.ebiom.2015.10.016 (2015).
 5. Yang, I. A. et al. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther 
Targets 15, 439–456, doi:10.1517/14728222.2011.555400 (2011).
 6. Sohal, S. S., Hansbro, P. M. & Walters, E. H. Epithelial Mesenchymal Transition in COPD, A Precursor for Epithelial Cancers: 
Understanding and Translation to Early Therapy. Annals of the American Thoracic Society. doi:10.1513/AnnalsATS.201705-387LE 
(2017).
 7. Sohal, S. et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the 
airways of smokers with chronic obstructive pulmonary disease. Respirology 15, 930–938 (2010).
 8. Sohal, S. et al. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 
12, 130 (2011).
www.nature.com/scientificreports/
1 1SCiENTifiC REPORTS | 7: 10832  | DOI:10.1038/s41598-017-11375-x
 9. Milara, J., Peiro, T., Serrano, A. & Cortijo, J. Epithelial to mesenchymal transition is increased in patients with COPD and induced 
by cigarette smoke. Thorax 68, 410–420, doi:10.1136/thoraxjnl-2012-201761 (2013).
 10. Shaykhiev, R. & Crystal, R. G. Early events in the pathogenesis of chronic obstructive pulmonary disease. Smoking-induced 
reprogramming of airway epithelial basal progenitor cells. Annals of the American Thoracic Society 11(Suppl 5), S252–258, 
doi:10.1513/AnnalsATS.201402-049AW (2014).
 11. Gohy, S. T. et al. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition. Eur Respir J 45, 
1258–1272, doi:10.1183/09031936.00135814 (2015).
 12. Mahmood, M. Q. et al. Transforming growth factor (TGF) beta1 and Smad signalling pathways: A likely key to EMT-associated 
COPD pathogenesis. Respirology 22, 133–140, doi:10.1111/resp.12882 (2017).
 13. Tian, X. et al. E-cadherin/beta-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011, 567305, 
doi:10.1155/2011/567305 (2011).
 14. Pongracz, J. E. & Stockley, R. A. Wnt signalling in lung development and diseases. Respir Res 7, 15, doi:10.1186/1465-9921-7-15 
(2006).
 15. Eger, A. et al. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial 
to mesenchymal transition. Oncogene 23, 2672–2680, doi:10.1038/sj.onc.1207416 (2004).
 16. Shin, S. Y. et al. Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that 
regulate epithelial-mesenchymal transition. Cancer Res 70, 6715–6724, doi:10.1158/0008-5472.can-10-1377 (2010).
 17. Heijink, I. H. et al. Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD. Eur Respir J. 
doi:10.1183/13993003.01541-2015 (2016).
 18. Fodde, R. & Brabletz, T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19, 150–158, 
doi:10.1016/j.ceb.2007.02.007 (2007).
 19. Hannigan, G., Troussard, A. A. & Dedhar, S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev 
Cancer 5, 51–63, doi:10.1038/nrc1524 (2005).
 20. Medici, D., Hay, E. D. & Goodenough, D. A. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-
induced epithelial-mesenchymal transition. Mol Biol Cell 17, 1871–1879, doi:10.1091/mbc.E05-08-0767 (2006).
 21. Nawshad, A. & Hay, E. D. TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal 
transformation during mouse palate development. J Cell Biol 163, 1291–1301, doi:10.1083/jcb.200306024 (2003).
 22. Peinado, H., Portillo, F. & Cano, A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 
48, 365–375, doi:10.1387/ijdb.041794hp (2004).
 23. Yook, J. I. et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8, 1398–1406, 
doi:10.1038/ncb1508 (2006).
 24. Vincent, T. et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal 
transition. Nat Cell Biol 11, 943–950, doi:10.1038/ncb1905 (2009).
 25. Peinado, H., Quintanilla, M. & Cano, A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: 
mechanisms for epithelial mesenchymal transitions. J Biol Chem 278, 21113–21123, doi:10.1074/jbc.M211304200 (2003).
 26. Ansieau, S. et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. 
Cancer Cell 14, 79–89, doi:10.1016/j.ccr.2008.06.005 (2008).
 27. Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19, 156–172, doi:10.1038/
cr.2009.5 (2009).
 28. Wang, J. et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 
882–887, doi:10.1038/nature05671 (2007).
 29. Oldenburger. A. et al. A-kinase anchoring proteins contribute to loss of E-cadherin and bronchial epithelial barrier by cigarette 
smoke. Am J Physiol Cell Physiol 306, doi:10.1152/ajpcell.00183.2013 (2014).
 30. Hogg, J. C., McDonough, J. E. & Suzuki, M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI 
imaging. Chest 143, 1436–1443, doi:10.1378/chest.12-1766 (2013).
 31. Dunnill, M. S. The classification and quantification of emphysema. Proc R Soc Med 62, 1024–1027 (1969).
 32. Prudkin, L. et al. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell 
carcinoma of the lung. Mod Pathol 22, 668–678, doi:10.1038/modpathol.2009.19 (2009).
 33. Mahmood, M. Q., Ward, C., Muller, H. K., Sohal, S. S. & Walters, E. H. Epithelial mesenchymal transition (EMT) and non-small cell 
lung cancer (NSCLC): a mutual association with airway disease. Medical oncology (Northwood, London, England) 34, 45, 
doi:10.1007/s12032-017-0900-y (2017).
 34. Mahmood, M. Q. et al. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction. 
Int J Chron Obstruct Pulmon Dis 10, 1515–1524, doi:10.2147/copd.s81032 (2015).
 35. Ryan, D. M. et al. Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2. PLoS One 9, e88051, 
doi:10.1371/journal.pone.0088051 (2014).
 36. Nowrin, K., Sohal, S. S., Peterson, G., Patel, R. & Walters, E. H. Epithelial-mesenchymal transition as a fundamental underlying 
pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med, 1–13, doi:10.1586/17476348.2014.94
8853 (2014).
 37. Jolly, M. K. et al. Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease. Dev 
Dyn, doi:10.1002/dvdy.24541 (2017).
 38. Cheon, S. S., Nadesan, P., Poon, R. & Alman, B. A. Growth factors regulate β-catenin-mediated TCF-dependent transcriptional 
activation in fibroblasts during the proliferative phase of wound healing. Experimental cell research 293, 267–274 (2004).
 39. Chilosi, M. et al. Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis. The American journal of pathology 
162, 1495–1502 (2003).
 40. Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127, 469–480 (2006).
 41. Nunes, R. O. et al. GSK-3/β-catenin signaling axis in airway smooth muscle: role in mitogenic signaling. Am J Physiol-Lung C 294, 
L1110–L1118 (2008).
 42. Guo, X. & Wang, X.-F. Signaling cross-talk between TGF-β/BMP and other pathways. Cell research 19, 71–88 (2009).
 43. Clifford, R. L., Deacon, K. & Knox, A. J. Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming 
Growth Factor β1 REQUIREMENT FOR Smads, β-CATENIN, AND GSK3β. Journal of Biological Chemistry 283, 35337–35353 
(2008).
 44. Doyle, J. L. & Haas, T. L. Differential role of β‐catenin in VEGF and histamine‐induced MMP‐2 production in microvascular 
endothelial cells. Journal of cellular biochemistry 107, 272–283 (2009).
 45. Rahmani, M. et al. Regulation of the versican promoter by the β-catenin-T-cell factor complex in vascular smooth muscle cells. 
Journal of Biological Chemistry 280, 13019–13028 (2005).
 46. Nagarajan, D., Melo, T., Deng, Z., Almeida, C. & Zhao, W. ERK/GSK3β/Snail signaling mediates radiation-induced alveolar 
epithelial-to-mesenchymal transition. Free Radical Biology and Medicine 52, 983–992, doi:10.1016/j.freeradbiomed.2011.11.024 
(2012).
 47. Xiong, S. et al. Regulatory T Cells Promote &#x3b2;-Catenin&#x2013;Mediated Epithelium-to-Mesenchyme Transition During 
Radiation-Induced Pulmonary Fibrosis. International Journal of Radiation Oncology • Biology • Physics 93, 425–435, doi:10.1016/j.
ijrobp.2015.05.043.
www.nature.com/scientificreports/
1 2SCiENTifiC REPORTS | 7: 10832  | DOI:10.1038/s41598-017-11375-x
 48. Baarsma, H. A. et al. Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β 1 is increased in chronic obstructive 
pulmonary disease. PLoS One 6, e25450 (2011).
 49. Nishioka, M. et al. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and 
COPD patients. Respiratory Research 16, 1–12, doi:10.1186/s12931-015-0232-4 (2015).
 50. Morin, P. J. β‐catenin signaling and cancer. Bioessays 21, 1021–1030 (1999).
 51. Li, J. & Zhou, B. P. Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer 
stem cell-like characters. BMC cancer 11, 49, doi:10.1186/1471-2407-11-49 (2011).
 52. Pozharskaya, V. et al. Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis. PLoS One 4, e7559, doi:10.1371/
journal.pone.0007559 (2009).
 53. Wang, Q., Wang, Y., Zhang, Y., Zhang, Y. & Xiao, W. The role of uPAR in epithelial-mesenchymal transition in small airway 
epithelium of patients with chronic obstructive pulmonary disease. Respir Res 14, 67, doi:10.1186/1465-9921-14-67 (2013).
 54. GOLD. Global Strategy for the Diagnosis, Mangement and Prevention of Chronic Obstructive Pulmonary Disease.Update 2007 
(2007).
 55. Eapen, M. S. et al. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology, 
doi:10.1111/resp.13021 (2017).
 56. Sohal, S. S. et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the 
airways of smokers with chronic obstructive pulmonary disease. Respirology 15, doi:10.1111/j.1440-1843.2010.01808.x (2010).
 57. Sohal, S. S. et al. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 
12, 130, doi:1465-9921-12-130 [pii] 10.1186/1465-9921-12-130 (2011).
 58. Sohal, S. S. et al. Changes in Airway Histone Deacetylase2 in Smokers and COPD with Inhaled Corticosteroids: A Randomized 
Controlled Trial. PLoS One 8, e64833, doi:10.1371/journal.pone.0064833 (2013).
 59. Sohal, S. S. et al. A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition 
(EMT) in large airway samples in COPD: an exploratory proof of concept study. Int J Chron Obstruct Pulmon Dis 9, 533–542, 
doi:10.2147/copd.s63911 (2014).
 60. Soltani, A. et al. Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD. Int J Chron Obstruct 
Pulmon Dis 11, 2359–2367, doi:10.2147/copd.s113176 (2016).
Acknowledgements
This research was supported by National Health and Medical Research Council (NHMRC) grant 1001062 and 
Clifford Craig Foundation (CCF) grant 153.The sponsors had no role in the study design; in the collection, 
analysis, and interpretation of the data; or in the decision to submit the article for publication.
Author Contributions
Dr. Mahmood: Performed the histological, statistical analysis, clinical assessment and writing of the paper. 
Prof. Walters: Designed the study and contribute to clinical assessments, overview of all analyses and writing 
of the paper. Dr. Shukla: Assisted in histological analysis. Mr. Weston: Advised on immunostaining and quality 
control. Prof. Muller: Advised on histology strategies and quality control. Dr. Ward: Project advisor and assisted 
in drafting of article. Dr. Sohal: Designed the study, overview of all analyses, assisted with clinical assessments, 
procurement of human tissue, performed some of the immunostains, assisted in histological and statistical 
analysis and writing of paper.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
